BRIEF-Ipsen says FDA grants priority review for somatuline depot 120mg injection

Sept 1 Mon Sep 1, 2014 1:13am EDT

Sept 1 (Reuters) - Ipsen SA :

* U.S. FDA has accepted and granted priority review of its supplemental new drug application (SNDA) for somatuline depot 120mg injection

* Decision expected in early Q1 2015 Source text for Eikon: [ID: nBw8ktJFja] Further company coverage: (Gdynia Newsroom: +48 58 698 39 20)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.